DNA Modifications: Function and Applications in Normal and Disease States

Biology

Volumn 3, Issue 4, 2014, Pages 670-723

  Liyanage, Vichithra R B ^a   Jarmasz, Jessica S ^b   Murugeshan, Nanditha ^a   Bigio, Marc R Del ^b   Rastegar, Mojgan ^a   Davie, James R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

5 hydroxymethylcytosine; 5 methylcytosine; Biomarkers; Brain development; Diabetes; DNA methylation; Methyl binding proteins; Neurological disorders; Teratogens

Indexed keywords

EID: 84908301632     PISSN: None     EISSN: 20797737     Source Type: Journal    
DOI: 10.3390/biology3040670     Document Type: Review

References (285)

1. Dahm, R. Friedrich Miescher and the discovery of DNA. Dev. Biol. 2005, 278, 274-288.
2. National Center for Biotechnology Information Pubmed Search "DNA". Available online: http://www.ncbi.nlm.nih.gov/pubmed/?term="DNA" (accessed on 23 March 2014).
3. National Human Genome Research Institute (NHGRI) The Human Genome Project. Available online: http://www.genome.gov/25019879 (accessed on 23 March 2014).
4. Hallgrimsson, B.; Hall, B.K. Epigenetics: Linking Genotype and Phenotype in Development and Evolution; University of California Press: Oakland, CA, USA, 2011.
5. Razin, A.; Cedar, H. Distribution of 5-methylcytosine in chromatin. Proc. Natl. Acad. Sci. USA 1977, 74, 2725-2728.
6. Pollack, Y.; Stein, R.; Razin, A.; Cedar, H. Methylation of foreign DNA sequences in eukaryotic cells. Proc. Natl. Acad. Sci. USA 1980, 77, 6463-6467.
7. Razin, A.; Riggs, A. DNA methylation and gene function. Science 1980, 2010, 604-610.
8. National Center for Biotechnology Information Pubmed Search "DNA Methylation". Available online: http://www.ncbi.nlm.nih.gov/pubmed/?term="DNA+methylation" (accessed on 14 May 2014).
9. Hashimoto, H.; Vertino, P.M.; Cheng, X. Molecular coupling of DNA methylation and histone methylation. Epigenomics 2010, 2, 657-669.
10. Schäfer, A.; Karaulanov, E.; Stapf, U.; Döderlein, G.; Niehrs, C. Ing1 functions in DNA demethylation by directing Gadd45a to H3K4me3. Genes. Dev. 2013, 27, 261-273.
11. Bian, C.; Xu, C.; Ruan, J.; Lee, K.K.; Burke, T.L.; Tempel, W.; Barsyte, D.; Li, J.; Wu, M.; Zhou, B.O.; et al. Sgf29 binds histone H3K4me2/3 and is required for SAGA complex recruitment and histone H3 acetylation. EMBO J. 2011, 30, 2829-2842.
12. Schram, A.W.; Baas, R.; Jansen, P.W.; Riss, A.; Tora, L.; Vermeulen, M.; Timmers, H.T. A dual role for SAGA-associated factor 29 (SGF29) in ER stress survival by coordination of both histone H3 acetylation and histone H3 lysine-4 trimethylation. PLoS One 2013, 8, e70035.
13. Ndlovu, M.N.; Denis, H.; Fuks, F. Exposing the DNA methylome iceberg. Trends Biochem. Sci. 2011, 36, 381-387.
14. Laurent, L.; Wong, E.; Li, G.; Huynh, T.; Tsirigos, A.; Ong, C.T.; Low, H.M.; Kin Sung, K.W.; Rigoutsos, I.; Loring, J.; Wei, C.-L. Dynamic changes in the human methylome during differentiation. Genome Res. 2010, 20, 320-331.
15. Guo, J.U.; Su, Y.; Zhong, C.; Ming, G.; Song, H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011, 145, 423-434.
16. Auclair, G.; Weber, M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie 2012, 94, 2202-2211.
17. Dahl, C.; Grønbæk, K.; Guldberg, P. Advances in DNA methylation: 5-hydroxymethylcytosine revisited. Clin. Chim. Acta 2011, 412, 831-836.
18. Ehrlich, M.; Lacey, M. Epigenetic Alterations in Oncogenesis; Karpf, A.R., Ed.; Springer New York: New York, NY, USA, 2013; Volume 754, pp. 31-56.
19. Kohli, R.M.; Zhang, Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 2013, 502, 472-479.
20. Jones, P.A; Liang, G. Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet. 2009, 10, 805-811.
21. Sharma, S.; de Carvalho, D.D.; Jeong, S.; Jones, P.A.; Liang, G. Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance. PLoS Genet. 2011, 7, e1001286.
22. Jeong, S.; Liang, G.; Sharma, S.; Lin, J.C.; Choi, S.H.; Han, H.; Yoo, C.B.; Egger, G.; Yang, A.S.; Jones, P.A. Selective anchoring of DNA methyltransferases 3A and 3B to nucleosomes containing methylated DNA. Mol. Cell. Biol. 2009, 29, 5366-5376.
23. Rose, N.R.; Klose, R.J. Understanding the relationship between DNA and histone lysine methylation. Biochim. Biophys. Acta 2014, doi: 10.1016/j.bbagrm.2014.02.007.
24. Nishiyama, A.; Yamaguchi, L.; Sharif, J.; Johmura, Y.; Kawamura, T.; Nakanishi, K.; Shimamura, S.; Arita, K.; Kodama, T.; Ishikawa, F.; et al. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature 2013, 502, 249-253.
25. Booth, M.J.; Branco, M.R.; Ficz, G.; Oxley, D.; Krueger, F.; Reik, W.; Balasubramanian, S. Quantitative Sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 2012, 336, 934-937.
26. Ponnaluri, V.K.C.; Maciejewski, J.P.; Mukherji, M. A mechanistic overview of TET-mediated 5-methylcytosine oxidation. Biochem. Biophys. Res. Commun. 2013, 436, 115-120.
27. Wu, H.; D'Alessio, A.C.; Ito, S.; Wang, Z.; Cui, K.; Zhao, K.; Sun, Y.E.; Zhang, Y. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes. Dev. 2011, 25, 679-684.
28. Stroud, H.; Feng, S.; Morey Kinney, S.; Pradhan, S.; Jacobsen, S.E. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 2011, 12, R54.
29. Tan, L.; Shi, Y.G. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 2012, 139, 1895-1902.
30. Okashita, N.; Kumaki, Y.; Ebi, K.; Nishi, M.; Okamoto, Y.; Nakayama, M.; Hashimoto, S.; Nakamura, T.; Sugasawa, K.; Kojima, N.; et al. PRDM14 promotes active DNA demethylation through the Ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells. Development 2014, 141, 269-280.
31. Moore, S.P.; Toomire, K.J.; Strauss, P.R. DNA modifications repaired by base excision repair are epigenetic. DNA Repair (Amst.) 2013, 12, 1152-1158.
32. Solary, E.; Bernard, O.A.; Tefferi, A.; Fuks, F.; Vainchenker, W. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia 2013, 2, 1-12.
33. Blaschke, K.; Ebata, K.T.; Karimi, M.M.; Zepeda-Martínez, J.A.; Goyal, P.; Mahapatra, S.; Tam, A.; Laird, D.J.; Hirst, M.; Rao, A.; et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 2013, 500, 222-226.
34. Minor, E.A.; Court, B.L.; Young, J.I.; Wang, G. Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem. 2013, 288, 13669-13674.
35. Liyanage, V.R.B.; Zachariah, R.M.; Delcuve, G.P.; Davie, J.R.; Rastegar, M. New Developments in Chromatin Research: An Epigenetic Perspective; Simpson, N.M., Stewart, V.J., Eds.; Nova Science Publishers: Hauppauge, NY, USA, 2012; pp. 29-58.
36. Mellen, M.; Ayata, P.; Dewell, S.; Kriaucionis, S.; Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 2012, 151, 1417-1430.
37. Baron, B. Breaking the Silence: The Interplay Between Transcription Factors and DNA Methylation. In Methylation-From DNA, RNA and Histones to Diseases and Treatment; Dricu, P.A., Ed.; InTech: Rijeka, Croatia, 2012.
38. Zhu, W.G.; Srinivasan, K.; Dai, Z.; Duan, W.; Druhan, L.J.; Ding, H.; Yee, L.; Villalona-Calero, M.A.; Plass, C.; Otterson, G.A. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol. Cell. Biol. 2003, 23, 4056-4065.
39. Collings, C.K.; Waddell, P.J.; Anderson, J.N. Effects of DNA methylation on nucleosome stability. Nucl. Acids Res. 2013, 41, 2918-2931.
40. Lee, J.Y.; Lee, T.H. Effects of DNA methylation on the structure of nucleosomes. J. Am. Chem. Soc. 2012, 134, 173-175.
41. Chodavarapu, R.K.; Feng, S.; Bernatavichute, Y.V.; Chen, P.Y.; Stroud, H.; Yu, Y.; Hetzel, J.A.; Kuo, F.; Kim, J.; Cokus, S.J.; et al. Relationship between nucleosome positioning and DNA methylation. Nature 2010, 466, 388-392.
42. Choy, J.S.; Wei, S.; Lee, J.Y.; Tan, S.; Chu, S.; Lee, T.H. DNA methylation increases nucleosome compaction and rigidity. J. Am. Chem. Soc. 2010, 132, 1782-1783.
43. Yang, X.; Noushmehr, H.; Han, H.; Andreu-Vieyra, C.; Liang, G.; Jones, P.A. Gene reactivation by 5-aza-2_-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. PLoS Genet. 2012, 8, e1002604.
44. Zachariah, R.M.; Rastegar, M. Linking epigenetics to human disease and Rett syndrome: The emerging novel and challenging concepts in MeCP2 research. Neural Plast. 2012, 2012, 415825.
45. Hashimoto, H.; Liu, Y.; Upadhyay, A.K.; Chang, Y.; Howerton, S.B.; Vertino, P.M.; Zhang, X.; Cheng, X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucl. Acids Res. 2012, 40, 4841-4849.
46. Cartron, P.F.; Nadaradjane, A.; Lepape, F.; Lalier, L.; Gardie, B.; Vallette, F.M. Identification of TET1 partners that control its dna-demethylating function. Genes. Cancer 2013, 4, 235-241.
47. Zhubi, A.; Chen, Y.; Dong, E.; Cook, E.H.; Guidotti, A.; Grayson, D.R. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl. Psychiatry 2014, 4, e349.
48. Anastasiadou, C.; Malousi, A.; Maglaveras, N.; Kouidou, S. Human epigenome data reveal increased CpG methylation in alternatively spliced sites and putative exonic splicing enhancers. DNA Cell Biol. 2011, 30, 267-275.
49. Choi, J.K. Contrasting chromatin organization of CpG islands and exons in the human genome. Genome Biol. 2010, 11, R70.
50. Malousi, A.; Kouidou, S. DNA hypermethylation of alternatively spliced and repeat sequences in humans. Mol. Genet. Genomics 2012, 287, 631-642.
51. Maunakea, A.K.; Chepelev, I.; Cui, K.; Zhao, K. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 2013, 23, 1256-1269.
52. Long, S.W.; Ooi, J.Y.; Yau, P.M.; Jones, P.L. A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing. Biosci. Rep. 2011, 31, 333-343.
53. Young, J.I.; Hong, E.P.; Castle, J.C.; Crespo-Barreto, J.; Bowman, A.B.; Rose, M.F.; Kang, D.; Richman, R.; Johnson, J.M.; Berget, S.; Zoghbi, H.Y. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. USA 2005, 102, 17551-17558.
54. Kornblihtt, A.R. CTCF: From insulators to alternative splicing regulation. Cell Res. 2012, 22, 450-452.
55. Shukla, S.; Kavak, E.; Gregory, M.; Imashimizu, M.; Shutinoski, B.; Kashlev, M.; Oberdoerffer, P.; Sandberg, R.; Oberdoerffer, S. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011, 479, 74-79.
56. Stadhouders, R.; Thongjuea, S.; Andrieu-Soler, C.; Palstra, R.J.; Bryne, J.C.; van den Heuvel, A.; Stevens, M.; de Boer, E.; Kockx, C.; van der Sloot, A.; et al. Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development. EMBO J. 2012, 31, 986-999.
57. Paredes, S.H.; Melgar, M.F.; Sethupathy, P. Promoter-proximal CCCTC-factor binding is associated with an increase in the transcriptional pausing index. Bioinformatics 2013, 29, 1485-1487.
58. Kubiura, M.; Okano, M.; Kimura, H.; Kawamura, F.; Tada, M. Chromosome-wide regulation of euchromatin-specific 5mC to 5hmC conversion in mouse ES cells and female human somatic cells. Chromosom. Res. 2012, 20, 837-848.
59. Alioui, A.; Wheldon, L.M.; Abakir, A.; Ferjentsik, Z.; Johnson, A.D.; Ruzov, A. 5-Carboxylcytosine is localized to euchromatic regions in the nuclei of follicular cells in axolotl ovary. Nucleus 2012, 3, 565-569.
60. Shen, L.; Wu, H.; Diep, D.; Yamaguchi, S.; D'Alessio, A.C.; Fung, H.L.; Zhang, K.; Zhang, Y. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 2013, 153, 692-706.
61. Skene, P.J.; Illingworth, R.S.; Webb, S.; Kerr, A.R.; James, K.D.; Turner, D.J.; Andrews, R.; Bird, A.P. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 2010, 37, 457-468.
62. Ghosh, R.P.; Horowitz-Scherer, R.A.; Nikitina, T.; Shlyakhtenko, L.S.; Woodcock, C.L. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Mol. Cell. Biol. 2010, 30, 4656-4670.
63. Nikitina, T.; Ghosh, R.P.; Horowitz-Scherer, R.A.; Hansen, J.C.; Grigoryev, S.A.; Woodcock, C.L. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J. Biol. Chem. 2007, 282, 28237-28245.
64. Yasui, D.H.; Peddada, S.; Bieda, M.C.; Vallero, R.O.; Hogart, A.; Nagarajan, R.P.; Thatcher, K.N.; Farnham, P.J.; Lasalle, J.M. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl. Acad. Sci. USA 2007, 104, 19416-19421.
65. Nikitina, T.; Shi, X.; Ghosh, R.P.; Horowitz-Scherer, R.A.; Hansen, J.C.; Woodcock, C.L. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol. Cell. Biol. 2007, 27, 864-877.
66. Phillips, J.E.; Corces, V.G. CTCF: Master weaver of the genome. Cell 2009, 137, 1194-1211.
67. Majumder, P.; Gomez, J.A.; Chadwick, B.P.; Boss, J.M. The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions. J. Exp. Med. 2008, 205, 785-798.
68. Holwerda, S.J.; de Laat, W. CTCF: The protein, the binding partners, the binding sites and their chromatin loops. Philos. Trans. R Soc. Lond. B Biol. Sci. 2013, 368, 20120369.
69. Handoko, L.; Xu, H.; Li, G.; Ngan, C.Y.; Chew, E.; Schnapp, M.; Lee, C.W.; Ye, C.; Ping, J.L.; Mulawadi, F.; et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat. Genet. 2011, 43, 630-638.
70. Botta, M.; Haider, S.; Leung, I.X.; Lio, P.; Mozziconacci, J. Intra- and inter-chromosomal interactions correlate with CTCF binding genome wide. Mol. Syst. Biol. 2010, 6, 426.
71. Gilbert, N.; Thomson, I.; Boyle, S.; Allan, J.; Ramsahoye, B.; Bickmore, W.A. DNA methylation affects nuclear organization, histone modifications, and linker histone binding but not chromatin compaction. J. Cell Biol. 2007, 177, 401-411.
72. Singleton, M.K.; Gonzales, M.L.; Leung, K.N.; Yasui, D.H.; Schroeder, D.I.; Dunaway, K.; LaSalle, J.M. MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation. Neurobiol. Dis. 2011, 43, 190-200.
73. Matarazzo, M.R.; Boyle, S.; D'Esposito, M.; Bickmore, W.A. Chromosome territory reorganization in a human disease with altered DNA methylation. Proc. Natl. Acad. Sci. USA 2007, 104, 16546-16551.
74. Huh, I.; Zeng, J.; Park, T.; Yi, S.V. DNA methylation and transcriptional noise. Epigenetics Chromatin 2013, 6, 9.
75. Della Ragione, F.; Filosa, S.; Scalabri, F.; D'Esposito, M. MeCP2 as a genome-wide modulator: The renewal of an old story. Front. Genet. 2012, 3, 181.
76. Miura, A.; Yonebayashi, S.; Watanabe, K.; Toyama, T.; Shimada, H.; Kakutani, T. Mobilization of transposons by a mutation abolishing full DNA methylation in Arabidopsis. Nature 2001, 411, 212-214.
77. Slotkin, R.K.; Martienssen, R. Transposable elements and the epigenetic regulation of the genome. Nat. Rev. Genet. 2007, 8, 272-285.
78. Leung, D.; Du, T.; Wagner, U.; Xie, W.; Lee, A.Y.; Goyal, P.; Li, Y.; Szulwach, K.E.; Jin, P.; Lorincz, M.C.; Ren, B. Regulation of DNA methylation turnover at LTR retrotransposons and imprinted loci by the histone methyltransferase Setdb1. Proc. Natl. Acad. Sci. 2014, 111, 6690-6695.
79. Lee, J.; Inoue, K.; Ono, R.; Ogonuki, N.; Kohda, T.; Kaneko-Ishino, T.; Ogura, A.; Ishino, F. Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells. Development 2002, 129, 1807-1817.
80. Yamaguchi, S.; Hong, K.; Liu, R.; Inoue, A.; Shen, L.; Zhang, K.; Zhang, Y. Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Res. 2013, 23, 329-339.
81. Hackett, J.A.; Sengupta, R.; Zylicz, J.J.; Murakami, K.; Lee, C.; Down, T.A.; Surani, M.A. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 2013, 339, 448-452.
82. Murphy, S.K.; Huang, Z.; Hoyo, C. Differentially methylated regions of imprinted genes in prenatal, perinatal and postnatal human tissues. PLoS One 2012, 7, e40924.
83. Coolen, M.W.; Statham, A.L.; Qu, W.; Campbell, M.J.; Henders, A.K.; Montgomery, G.W.; Martin, N.G.; Clark, S.J. Impact of the genome on the epigenome is manifested in DNA methylation patterns of imprinted regions in monozygotic and dizygotic twins. PLoS One 2011, 6, e25590.
84. Kernohan, K.D.; Bérubé, N.G. Genetic and epigenetic dysregulation of imprinted genes in the brain. Epigenomics 2010, 2, 743-763.
85. Court, F.; Martin-Trujillo, A.; Romanelli, V.; Garin, I.; Iglesias-Platas, I.; Salafsky, I.; Guitart, M.; Perez de Nanclares, G.; Lapunzina, P.; Monk, D. Genome-wide allelic methylation analysis reveals disease-specific susceptibility to multiple methylation defects in imprinting syndromes. Hum. Mutat. 2013, 34, 595-602.
86. Soubry, A.; Murphy, S.K.; Wang, F.; Huang, Z.; Vidal, A.C.; Fuemmeler, B.F.; Kurtzberg, J.; Murtha, A.; Jirtle, R.L.; Schildkraut, J.M.; et al. Newborns of obese parents have altered DNA methylation patterns at imprinted genes. Int. J. Obes. 2013, doi:10.1038/ijo.2013.193.
87. LaSalle, J.M. The Odyssey of MeCP2 and parental imprinting. Epigenetics 2007, 2, 5-10.
88. Flashner, B.M.; Russo, M.E.; Boileau, J.E.; Leong, D.W.; Gallicano, G.I. Epigenetic factors and autism spectrum disorders. NeuroMol. Med. 2013, 15, 339-350.
89. Lewis, A.; Murrell, A. Genomic imprinting: CTCF protects the boundaries. Curr. Biol. 2004, 14, R284-R286.
90. Prickett, A.R.; Barkas, N.; McCole, R.B.; Hughes, S.; Amante, S.M.; Schulz, R.; Oakey, R.J. Genome-wide and parental allele-specific analysis of CTCF and cohesin DNA binding in mouse brain reveals a tissue-specific binding pattern and an association with imprinted differentially methylated regions. Genome Res. 2013, 23, 1624-1635.
91. Zuo, X.; Sheng, J.; Lau, H.-T.; McDonald, C.M.; Andrade, M.; Cullen, D.E.; Bell, F.T.; Iacovino, M.; Kyba, M.; Xu, G.; et al. Zinc finger protein ZFP57 requires its co-factor to recruit DNA methyltransferases and maintains DNA methylation imprint in embryonic stem cells via its transcriptional repression domain. J. Biol. Chem. 2012, 287, 2107-2118.
92. Quenneville, S.; Verde, G.; Corsinotti, A.; Kapopoulou, A.; Jakobsson, J.; Offner, S.; Baglivo, I.; Pedone, P.V.; Grimaldi, G.; Riccio, A.; et al. In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions. Mol. Cell 2011, 44, 361-372.
93. Pontier, D.B.; Gribnau, J. Xist regulation and function explored. Hum. Genet. 2011, 130, 223-236.
94. Marks, H.; Chow, J.C.; Denissov, S.; Françoijs, K.-J.; Brockdorff, N.; Heard, E.; Stunnenberg, H.G. High-resolution analysis of epigenetic changes associated with X inactivation. Genome Res. 2009, 19, 1361-1373.
95. Ahn, J.Y.; Lee, J.T. X chromosome: X inactivation. Nat. Educ. 2008, 1, 24.
96. Escamilla-Del-Arenal, M.; da Rocha, S.T.; Heard, E. Evolutionary diversity and developmental regulation of X-chromosome inactivation. Hum. Genet. 2011, 130, 307-327.
97. Sharp, A.J.; Stathaki, E.; Migliavacca, E.; Brahmachary, M.; Montgomery, S.B.; Dupre, Y.; Antonarakis, S.E. DNA methylation profiles of human active and inactive X chromosomes. Genome Res. 2011, 21, 1592-1600.
98. Hellman, A.; Chess, A. Gene body-specific methylation on the active X chromosome. Science 2007, 315, 1141-1143.
99. Migeon, B.R.; Chowdhury, A.K.; Dunston, J.A.; McIntosh, I. Identification of TSIX, encoding an RNA antisense to human XIST, reveals differences from its murine counterpart: Implications for X inactivation. Am. J. Hum. Genet. 2001, 69, 951-960.
100. Neri, F.; Krepelova, A.; Incarnato, D.; Maldotti, M.; Parlato, C.; Galvagni, F.; Matarese, F.; Stunnenberg, H.G.; Oliviero, S. Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 2013, 155, 121-134.
101. Brinkman, A.B.; Gu, H.; Bartels, S.J.; Zhang, Y.; Matarese, F.; Simmer, F.; Marks, H.; Bock, C.; Gnirke, A.; Meissner, A.; et al. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res. 2012, 22, 1128-1138.
102. Nesterova, T.B.; Popova, B.C.; Cobb, B.S.; Norton, S.; Senner, C.E.; Tang, Y.A.; Spruce, T.; Rodriguez, T.A.; Sado, T.; Merkenschlager, M.; et al. Dicer regulates Xist promoter methylation in ES cells indirectly through transcriptional control of Dnmt3a. Epigenetics Chromatin 2008, 1, 2.
103. Navarro, P.; Pichard, S.; Ciaudo, C.; Avner, P.; Rougeulle, C. Tsix transcription across the Xist gene alters chromatin conformation without affecting Xist transcription: Implications for X-chromosome inactivation. Genes Dev. 2005, 19, 1474-1484.
104. Chao, W.; Huynh, K.D.; Spencer, R.J.; Davidow, L.S.; Lee, J.T. CTCF, a candidate trans-acting factor for X-inactivation choice. Science 2002, 295, 345-347.
105. Zhou, Q.; Teng, F. Epigenetic re-programming during mammalian preimplantation embryogenesis and pgc development. J. IVF Reprod Med. Genet. 2013, 1, 114.
106. Lan, J.; Hua, S.; He, X.; Zhang, Y. DNA methyltransferases and methyl-binding proteins of mammals. Acta Biochim. Biophys. Sin. 2010, 42, 243-252.
107. Saito, M.; Ishikawa, F. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J. Biol. Chem. 2002, 277, 35434-35439.
108. Prokhortchouk, A.; Hendrich, B.; Jorgensen, H.; Ruzov, A.; Wilm, M.; Georgiev, G.; Bird, A.; Prokhortchouk, E. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 2001, 15, 1613-1618.
109. Liyanage, V.R.; Rastegar, M. Rett Syndrome and MeCP2. Neuromol. Med. 2014, 16, 231-264.
110. Fraga, M.F.; Ballestar, E.; Montoya, G.; Taysavang, P.; Wade, P.A.; Esteller, M. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucl. Acids Res. 2003, 31, 1765-1774.
111. Klose, R.J.; Sarraf, S.A.; Schmiedeberg, L.; McDermott, S.M.; Stancheva, I.; Bird, A.P. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol. Cell 2005, 19, 667-678.
112. Clouaire, T.; de Las Heras, J.I.; Merusi, C.; Stancheva, I. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucl. Acids Res. 2010, 38, 4620-4634.
113. Scarsdale, J.N.; Webb, H.D.; Ginder, G.D.; Williams, D.C., Jr. Solution structure and dynamic analysis of chicken MBD2 methyl binding domain bound to a target-methylated DNA sequence. Nucl. Acids Res. 2011, 39, 6741-6752.
114. Spruijt, C.G.; Gnerlich, F.; Smits, A.H.; Pfaffeneder, T.; Jansen, P.W.; Bauer, C.; Munzel, M.; Wagner, M.; Muller, M.; Khan, F.; et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152, 1146-1159.
115. Iurlaro, M.; Ficz, G.; Oxley, D.; Raiber, E.A.; Bachman, M.; Booth, M.J.; Andrews, S.; Balasubramanian, S.; Reik, W. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol 2013, 14, R119.
116. Yildirim, O.; Li, R.; Hung, J.H.; Chen, P.B.; Dong, X.; Ee, L.S.; Weng, Z.; Rando, O.J.; Fazzio, T.G. Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 2011, 147, 1498-1510.
117. Baubec, T.; Ivanek, R.; Lienert, F.; Schubeler, D. Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell 2013, 153, 480-492.
118. Hansen, J.C.; Ghosh, R.P.; Woodcock, C.L. Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. IUBMB Life 2010, 62, 732-738.
119. Ghosh, R.P.; Nikitina, T.; Horowitz-Scherer, R.A.; Gierasch, L.M.; Uversky, V.N.; Hite, K.; Hansen, J.C.; Woodcock, C.L. Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Biochemistry 2010, 49, 4395-4410.
120. Jorgensen, H.F.; Ben-Porath, I.; Bird, A.P. Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains. Mol. Cell. Biol. 2004, 24, 3387-3395.
121. Cramer, J.M.; Scarsdale, J.N.; Walavalkar, N.M.; Buchwald, W.A.; Ginder, G.D.; Williams, D.C., Jr. Probing the dynamic distribution of bound states for methylcytosine-binding domains on DNA. J. Biol. Chem. 2014, 289, 1294-1302.
122. Parry, L.; Clarke, A.R. The Roles of the Methyl-CpG Binding Proteins in Cancer. Genes Cancer 2011, 2, 618-630.
123. Kimura, H.; Shiota, K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem. 2003, 278, 4806-4812.
124. Heard, E.; Martienssen, R.A. Transgenerational epigenetic inheritance: Myths and mechanisms. Cell 2014, 157, 95-109.
125. Dayeh, T.A.; Olsson, A.H.; Volkov, P.; Almgren, P.; Ronn, T.; Ling, C. Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia 2013, 56, 1036-1046.
126. Taqi, M.M.; Bazov, I.; Watanabe, H.; Sheedy, D.; Harper, C.; Alkass, K.; Druid, H.; Wentzel, P.; Nyberg, F.; Yakovleva, T.; Bakalkin, G. Prodynorphin CpG-SNPs associated with alcohol dependence: Elevated methylation in the brain of human alcoholics. Addict. Biol. 2011, 16, 499-509.
127. Chik, F.; Szyf, M.; Rabbani, S.A. Role of epigenetics in cancer initiation and progression. Adv. Exp. Med. Biol. 2011, 720, 91-104.
128. Yaqinuddin, A.; Abbas, F.; Naqvi, S.Z.; Bashir, M.U.; Qazi, R.; Qureshi, S.A. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes. Biosci. Rep. 2008, 28, 319-326.
129. Fournier, A.; Sasai, N.; Nakao, M.; Defossez, P.A. The role of methyl-binding proteins in chromatin organization and epigenome maintenance. Br. Funct. Genomics. 2012, 11, 251-264.
130. Wang, Z.; Zhang, J.; Zhang, Y.; Srivenugopal, K.S.; Lim, S.H. SPAN-XB core promoter sequence is regulated in myeloma cells by specific CpG dinucleotides associated with the MeCP2 protein. Int. J. Cancer 2006, 119, 2878-2884.
131. Pontes, T.B.; Chen, E.S.; Gigek, C.O.; Calcagno, D.Q.; Wisnieski, F.; Leal, M.F.; Demachki, S.; Assumpcao, P.P.; Artigiani, R.; Lourenco, L.G.; et al. Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis. Tumour Biol. 2013, 35, 3447-3453.
132. Sapkota, Y.; Robson, P.; Lai, R.; Cass, C.E.; Mackey, J.R.; Damaraju, S. A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility. Eur. J. Hum. Genet. 2012, 20, 682-689.
133. Stefanska, B.; Suderman, M.; Machnes, Z.; Bhattacharyya, B.; Hallett, M.; Szyf, M. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. Carcinogenesis 2013, 34, 2738-2749.
134. Zhao, S.; Choi, M.; Overton, J.D.; Bellone, S.; Roque, D.M.; Cocco, E.; Guzzo, F.; English, D.P.; Varughese, J.; Gasparrini, S.; et al. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proc. Natl. Acad. Sci. USA 2013, 110, 2916-2921.
135. Hendrich, B.; Guy, J.; Ramsahoye, B.; Wilson, V.A.; Bird, A. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 2001, 15, 710-723.
136. Kaji, K.; Caballero, I.M.; MacLeod, R.; Nichols, J.; Wilson, V.A.; Hendrich, B. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat. Cell Biol. 2006, 8, 285-292.
137. Xiong, X.D.; Luo, X.P.; Liu, X.; Jing, X.; Zeng, L.Q.; Lei, M.; Hong, X.S.; Chen, Y. The MBD4 Glu346Lys polymorphism is associated with the risk of cervical cancer in a Chinese population. Int. J. Gynecol. Cancer 2012, 22, 1552-1556.
138. Jones, J.; Wang, H.; Karanam, B.; Theodore, S.; Dean-Colomb, W.; Welch, D.R.; Grizzle, W.; Yates, C. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin. Exp. Metastasis 2014, 31, 497-510.
139. Vermeulen, J.F.; van de Ven, R.A.; Ercan, C.; van der Groep, P.; van der Wall, E.; Bult, P.; Christgen, M.; Lehmann, U.; Daniel, J.; van Diest, P.J.; et al. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer. PLoS One 2012, 7, e37864.
140. Dai, S.D.; Wang, Y.; Jiang, G.Y.; Zhang, P.X.; Dong, X.J.; Wei, Q.; Xu, H.T.; Li, Q.C.; Zhao, C.; Wang, E.H. Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn. Lung Cancer 2010, 67, 205-215.
141. Ling, C.; Groop, L. Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes 2009, 58, 2718-2725.
142. Shaikh, M.K.; Devrajani, B.R.; Shaikh, A.; Shah, S.Z.A.; Shaikh, S.; Singh, D. Plasma homocysteine level in patients with diabetes mellitus. World Appl. Sci. J. 2012, 16, 1269-1273.
143. Zheng, M.; Zhang, M.; Yang, J.; Zhao, S.; Qin, S.; Chen, H.; Gao, Y.; Huang, G. Relationship between blood levels of methyl donor and folate and mild cognitive impairment in Chinese patients with type 2 diabetes: A case-control study. J. Clin. Biochem. Nutr. 2014, 54, 122-128.
144. Al-Maskari, M.Y.; Waly, M.I.; Ali, A.; Al-Shuaibi, Y.S.; Ouhtit, A. Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition 2012, 28, e23-e26.
145. Dominguez, R.O.; Marschoff, E.R.; Guareschi, E.M.; Famulari, A.L.; Pagano, M.A.; Serra, J.A. Homocysteine, vitamin B12 and folate in Alzheimer's and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition. Clin. Chim. Acta 2005, 359, 163-170.
146. Belot, M.-P.; Fradin, D.; Mai, N.; Le Fur, S.; Zélénika, D.; Kerr-Conte, J.; Pattou, F.; Lucas, B.; Bougnères, P. CpG methylation changes within the IL2RA promoter in type 1 diabetes of childhood onset. PLoS One 2013, 8, e68093.
147. Ling, C.; del Guerra, S.; Lupi, R.; Ronn, T.; Granhall, C.; Luthman, H.; Masiello, P.; Marchetti, P.; Groop, L.; del Prato, S. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008, 51, 615-622.
148. Hall, E.; Dayeh, T.; Kirkpatrick, C.L.; Wollheim, C.B.; Dekker Nitert, M.; Ling, C. DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets. BMC Med. Genet. 2013, 14, 76.
149. Yang, B.T.; Dayeh, T.A.; Volkov, P.A.; Kirkpatrick, C.L.; Malmgren, S.; Jing, X.; Renstrom, E.; Wollheim, C.B.; Nitert, M.D.; Ling, C. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrinol. 2012, 26, 1203-1212.
150. Zhang, H.; Cai, X.; Yi, B.; Huang, J.; Wang, J.; Sun, J. Correlation of CTGF gene promoter methylation with CTGF expression in type 2 diabetes mellitus with or without nephropathy. Mol. Med. Rep. 2014, 9, 2138-2144.
151. Kuroda, A.; Rauch, T.A.; Todorov, I.; Ku, H.T.; Al-Abdullah, I.H.; Kandeel, F.; Mullen, Y.; Pfeifer, G.P.; Ferreri, K. Insulin gene expression is regulated by DNA methylation. PLoS One 2009, 4, e6953.
152. Pitcher, M.R.; Ward, C.S.; Arvide, E.M.; Chapleau, C.A.; Pozzo-Miller, L.; Hoeflich, A.; Sivaramakrishnan, M.; Saenger, S.; Metzger, F.; Neul, J.L. Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function. Hum. Mol. Genet. 2013, 22, 2626-2633.
153. Akin, L.; Adal, E.; Akin, M.A.; Kurtoglu, S. A case of diabetes mellitus associated with Rett syndrome. J. Pediatr. Endocrinol. Metab. 2012, 25, 197-198.
154. Rekik, N.M.; Kamoun, M.; Mnif, F.; Charfi, N.; Mnif, M.F.; Abid, M. Type 1 diabetes mellitus and Rett syndrome: Is there a link? J. Endocrinol. Invest. 2010, 33, 851.
155. Kurtoglu, S.; Atabek, M.E.; Kumandas, S.; Keskin, M. Diabetes mellitus type 1: Association with Rett syndrome. Pediatr. Int. 2005, 47, 90-91.
156. Butler, M.G. Genomic imprinting disorders in humans: A mini-review. J. Assist. Reprod. Genet. 2009, 26, 477-486.
157. Sharp, A.J.; Migliavacca, E.; Dupre, Y.; Stathaki, E.; Sailani, M.R.; Baumer, A.; Schinzel, A.; Mackay, D.J.; Robinson, D.O.; Cobellis, G.; et al. Methylation profiling in individuals with uniparental disomy identifies novel differentially methylated regions on chromosome 15. Genome Res. 2010, 20, 1271-1278.
158. Dias, R.P.; Bogdarina, I.; Cazier, J.B.; Buchanan, C.; Donaldson, M.C.; Johnston, L.B.; Hokken-Koelega, A.C.; Clark, A.J. Multiple segmental uniparental disomy associated with abnormal DNA methylation of imprinted Loci in silver-russell syndrome. J. Clin. Endocrinol. Metab. 2012, 97, E2188-E2193.
159. Han, K.; Gennarino, V.A.; Lee, Y.; Pang, K.; Hashimoto-Torii, K.; Choufani, S.; Raju, C.S.; Oldham, M.C.; Weksberg, R.; Rakic, P.; Liu, Z.; Zoghbi, H.Y. Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p. Genes Dev. 2013, 27, 485-490.
160. Drewell, R.A.; Goddard, C.J.; Thomas, J.O.; Surani, M.A. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucl. Acids Res. 2002, 30, 1139-1144.
161. Fuks, F.; Hurd, P.J.; Wolf, D.; Nan, X.; Bird, A.P.; Kouzarides, T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 2003, 278, 4035-4040.
162. Makedonski, K.; Abuhatzira, L.; Kaufman, Y.; Razin, A.; Shemer, R. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet. 2005, 14, 1049-1058.
163. Samaco, R.C.; Hogart, A.; LaSalle, J.M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 2005, 14, 483-492.
164. Horike, S.; Cai, S.; Miyano, M.; Cheng, J.F.; Kohwi-Shigematsu, T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 2005, 37, 31-40.
165. Shukla, S.D.; Velazquez, J.; French, S.W.; Lu, S.C.; Ticku, M.K.; Zakhari, S. Emerging role of epigenetics in the actions of alcohol. Alcohol. Clin. Exp. Res. 2008, 32, 1525-1534.
166. Wang, T.; Nandakumar, V.; Jiang, X.X.; Jones, L.; Yang, A.G.; Huang, X.F.; Chen, S.Y. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation. Blood 2013, 122, 2812-2822.
167. Beerman, I.; Bock, C.; Garrison, B.S.; Smith, Z.D.; Gu, H.; Meissner, A.; Rossi, D.J. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell 2013, 12, 413-425.
168. Hogart, A.; Lichtenberg, J.; Ajay, S.S.; Anderson, S.; Margulies, E.H.; Bodine, D.M. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res. 2012, 22, 1407-1418.
169. Suarez-Alvarez, B.; Rodriguez, R.M.; Fraga, M.F.; Lopez-Larrea, C. DNA methylation: A promising landscape for immune system-related diseases. Trends Genet. 2012, 28, 506-514.
170. Friez, M.J.; Jones, J.R.; Clarkson, K.; Lubs, H.; Abuelo, D.; Bier, J.A.; Pai, S.; Simensen, R.; Williams, C.; Giampietro, P.F.; Schwartz, C.E.; Stevenson, R.E. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 2006, 118, e1687-e1695.
171. Yang, T.; Ramocki, M.B.; Neul, J.L.; Lu, W.; Roberts, L.; Knight, J.; Ward, C.S.; Zoghbi, H.Y.; Kheradmand, F.; Corry, D.B. Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses. Sci. Transl. Med. 2012, 4, 1-10.
172. Sawalha, A.H.; Webb, R.; Han, S.; Kelly, J.A.; Kaufman, K.M.; Kimberly, R.P.; Alarcon-Riquelme, M.E.; James, J.A.; Vyse, T.J.; Gilkeson, G.S.; et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 2008, 3, e1727.
173. Sawalha, A.H. Overexpression of methyl-CpG-binding protein 2 and autoimmunity: Evidence from MECP2 duplication syndrome, lupus, MECP2 transgenic and Mecp2 deficient mice. Lupus 2013, 22, 870-872.
174. Cobb, B.L.; Fei, Y.; Jonsson, R.; Bolstad, A.I.; Brun, J.G.; Rischmueller, M.; Lester, S.E.; Witte, T.; Illei, G.; Brennan, M.; et al. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome. Ann. Rheum. Dis. 2010, 69, 1731-1732.
175. Szyf, M. Epigenetic therapeutics in autoimmune disease. Clin. Rev. Allergy Immunol. 2010, 39, 62-77.
176. Balada, E.; Ordi-Ros, J.; Vilardell-Tarres, M. DNA methylation and systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 2007, 1108, 127-136.
177. Balada, E.; Ordi-Ros, J.; Serrano-Acedo, S.; Martinez-Lostao, L.; Vilardell-Tarres, M. Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J. Leukoc. Biol. 2007, 81, 1609-1616.
178. Udali, S.; Guarini, P.; Moruzzi, S.; Choi, S.W.; Friso, S. Cardiovascular epigenetics: From DNA methylation to microRNAs. Mol. Aspects Med. 2013, 34, 883-901.
179. Handy, D.E.; Castro, R.; Loscalzo, J. Epigenetic modifications: Basic mechanisms and role in cardiovascular disease. Circulation 2011, 123, 2145-2156.
180. Baccarelli, A.; Wright, R.; Bollati, V.; Litonjua, A.; Zanobetti, A.; Tarantini, L.; Sparrow, D.; Vokonas, P.; Schwartz, J. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 2010, 21, 819-828.
181. Endres, M.; Meisel, A.; Biniszkiewicz, D.; Namura, S.; Prass, K.; Ruscher, K.; Lipski, A.; Jaenisch, R.; Moskowitz, M.A.; Dirnagl, U. DNA methyltransferase contributes to delayed ischemic brain injury. J. Neurosci. 2000, 20, 3175-3181.
182. Endres, M.; Fan, G.; Meisel, A.; Dirnagl, U.; Jaenisch, R. Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons. Neuroreport 2001, 12, 3763-3766.
183. Lin, R.-T.; Hsi, E.; Lin, H.-F.; Liao, Y.-C.; Wang, Y.-S.; Juo, S.-H. LINE-1 methylation is associated with an increased risk of ischemic stroke in men. Curr. Neurovasc. Res. 2014, 11, 4-9.
184. Schweizer, S.; Meisel, A.; Märschenz, S. Epigenetic mechanisms in cerebral ischemia. J. Cereb. Blood Flow Metab. 2013, 33, 1335-1346.
185. Lusardi, T.A.; Farr, C.D.; Faulkner, C.L.; Pignataro, G.; Yang, T.; Lan, J.; Simon, R.P.; Saugstad, J.A. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 2010, 30, 744-756.
186. Gan, H.; Wen, L.; Liao, S.; Lin, X.; Ma, T.; Liu, J.; Song, C.X.; Wang, M.; He, C.; Han, C.; et al. Dynamics of 5-hydroxymethylcytosine during mouse spermatogenesis. Nat. Commun. 2013, 4, 1995.
187. Klenova, E.M.; Nicolas, R.H.; Paterson, H.F.; Carne, A.F.; Heath, C.M.; Goodwin, G.H.; Neiman, P.E.; Lobanenkov, V.V. CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms. Mol. Cell. Biol. 1993, 13, 7612-7624.
188. Szabo, P.E.; Tang, S.H.; Silva, F.J.; Tsark, W.M.; Mann, J.R. Role of CTCF binding sites in the Igf2/H19 imprinting control region. Mol. Cell. Biol. 2004, 24, 4791-4800.
189. Zlatanova, J.; Caiafa, P. CTCF and its protein partners: Divide and rule? J. Cell Sci. 2009, 122, 1275-1284.
190. Gause, M.; Schaaf, C.A.; Dorsett, D. Cohesin and CTCF: Cooperating to control chromosome conformation? Bioessays 2008, 30, 715-718.
191. Chernukhin, I.; Shamsuddin, S.; Kang, S.Y.; Bergstrom, R.; Kwon, Y.W.; Yu, W.; Whitehead, J.; Mukhopadhyay, R.; Docquier, F.; Farrar, D.; et al. CTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wide. Mol. Cell. Biol. 2007, 27, 1631-1648.
192. Donohoe, M.E.; Zhang, L.F.; Xu, N.; Shi, Y.; Lee, J.T. Identification of a Ctcf cofactor, YY1, for the X chromosome binary switch. Mol. Cell 2007, 25, 43-56.
193. Aulmann, S.; Blaker, H.; Penzel, R.; Rieker, R.J.; Otto, H.F.; Sinn, H.P. CTCF gene mutations in invasive ductal breast cancer. Breast Cancer Res. Treat. 2003, 80, 347-352.
194. Docquier, F.; Farrar, D.; D'Arcy, V.; Chernukhin, I.; Robinson, A.F.; Loukinov, D.; Vatolin, S.; Pack, S.; Mackay, A.; Harris, R.A.; et al. Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis. Cancer Res. 2005, 65, 5112-5122.
195. Paradowska, A.; Fenic, I.; Konrad, L.; Sturm, K.; Wagenlehner, F.; Weidner, W.; Steger, K. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia. Int. J. Oncol. 2009, 35, 87-96.
196. Fiorentino, F.P.; Macaluso, M.; Miranda, F.; Montanari, M.; Russo, A.; Bagella, L.; Giordano, A. CTCF and BORIS regulate Rb2/p130 gene transcription: A novel mechanism and a new paradigm for understanding the biology of lung cancer. Mol. Cancer Res. 2011, 9, 225-233.
197. Nakagawa, H.; Chadwick, R.B.; Peltomaki, P.; Plass, C.; Nakamura, Y.; de La Chapelle, A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl. Acad. Sci. USA 2001, 98, 591-596.
198. Weksberg, R.; Smith, A.C.; Squire, J.; Sadowski, P. Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum. Mol. Genet. 2003, 12, R61-R68.
199. Nagarajan, R.P.; Patzel, K.A.; Martin, M.; Yasui, D.H.; Swanberg, S.E.; Hertz-Picciotto, I.; Hansen, R.L.; van de Water, J.; Pessah, I.N.; Jiang, R.; Robinson, W.P.; LaSalle, J.M. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res. 2008, 1, 169-178.
200. Stiles, J.; Jernigan, T.L. The basics of brain development. Neuropsychol. Rev. 2010, 20, 327-348.
201. Sadler, T.W. Embryology of neural tube development. Am. J. Med. Genet. C. Semin. Med. Genet. 2005, 135C, 2-8.
202. O'Rahilly, R.R.; Muller, F. The Embryonic Human Brain: An Atlas of Developmental Stages; 2rd ed.; Wiley-Liss: Toronto, Canada, 1999.
203. Morgan, H.D.; Santos, F.; Green, K.; Dean, W.; Reik, W. Epigenetic reprogramming in mammals. Hum. Mol. Genet. 2005, 14, R47-R58.
204. Seisenberger, S.; Peat, J.R.; Hore, T.A.; Santos, F.; Dean, W.; Reik, W. Reprogramming DNA methylation in the mammalian life cycle: Building and breaking epigenetic barriers. Philasophical Trans. R. Soc. Biol. Sci. 2013, 368, 1-11.
205. Zhou, F.C. DNA methylation program during development. Front. Biol. (Beijing) 2012, 7, 485-494.
206. Chen, Y.; Damayanti, N.P.; Irudayaraj, J.; Dunn, K.; Zhou, F.C. Diversity of two forms of DNA methylation in the brain. Front. Genet. 2014, 5, 46.
207. Chen, Y.; Ozturk, N.C.; Zhou, F.C. DNA methylation program in developing hippocampus and its alteration by alcohol. PLoS One 2013, 8, e60503.
208. Lister, R.; Mukamel, E.A.; Nery, J.R.; Urich, M.; Puddifoot, C.A.; Johnson, N.D.; Lucero, J.; Huang, Y.; Dwork, A.J.; Schultz, M.D.; et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341, 1237905.
209. Guo, J.U.; Su, Y.; Shin, J.H.; Shin, J.; Li, H.; Xie, B.; Zhong, C.; Hu, S.; Le, T.; Fan, G.; et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci. 2014, 17, 215-222.
210. LaSalle, J.M. A genomic point-of-view on environmental factors influencing the human brain methylome. Epigenetics 2011, 6, 862-869.
211. Perera, F.; Herbstman, J. Prenatal environmental exposures, epigenetics, and disease. Reprod. Toxicol. 2011, 31, 363-373.
212. Israel, Y.; Rivera-Meza, M.; Karahanian, E.; Quintanilla, M.E.; Tampier, L.; Morales, P.; Herrera-Marschitz, M. Gene specific modifications unravel ethanol and acetaldehyde actions. Front. Behav. Neurosci. 2013, 7, 80.
213. Behnke, M.; Smith, V.C. Prenatal substance abuse: Short- and long-term effects on the exposed fetus. Pediatrics 2013, 131, e1009-e1024.
214. Tian, W.; Zhao, M.; Li, M.; Song, T.; Zhang, M.; Quan, L.; Li, S.; Sun, Z.S. Reversal of cocaine-conditioned place preference through methyl supplementation in mice: Altering global DNA methylation in the prefrontal cortex. PLoS One 2012, 7, e33435.
215. Satta, R.; Maloku, E.; Zhubi, A.; Pibiri, F.; Hajos, M.; Costa, E.; Guidotti, A. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. PNAS 2008, 105, 16356-16361.
216. Liu, Y.; Balaraman, Y.; Wang, G.; Nephew, K.P.; Zhou, F.C. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics 2009, 4, 500-511.
217. Zhou, F.C.; Balaraman, Y.; Teng, M.; Liu, Y.; Singh, R.P.; Nephew, K.P. Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiation. Alcohol. Clin. Exp. Res. 2011, 35, 735-746.
218. Varela-Rey, M.; Woodhoo, A.; Martinez-Chantar, M.-L.; Mato, J.M.; Lu, S.C. Alcohol, DNA methylation, and cancer. Alcohol Res. Curr. Rev. 2011, 25-35.
219. Kruman, I.; Fowler, A.-K. One-carbon metabolism and risk factors for its disturbance. J. Neurochem. 2014, 129, 770-780.
220. Laufer, B.I.; Mantha, K.; Kleiber, M.L.; Diehl, E.J.; Addison, S.M.F.; Singh, S.M. Long-lasting alterations to DNA methylation and ncRNAs could underlie the effects of fetal alcohol exposure in mice. Dis. Model. Mech. 2013, 6, 977-992.
221. Bielawski, D.M.; Zaher, F.M.; Svinarich, D.M.; Abel, E.L. Paternal alcohol exposure affects sperm cytosine methyltransferase messenger RNA levels. Alcohol. Clin. Exp. Res. 2002, 26, 347-351.
222. Ouko, L.A.; Shantikumar, K.; Knezovich, J.; Haycock, P.; Schnugh, D.J.; Ramsay, M. Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H19 and IG-DMR in male gametes: Implications for fetal alcohol spectrum disorders. Alcohol. Clin. Exp. Res. 2009, 33, 1615-1627.
223. Stouder, C.; Somm, E.; Paoloni-Giacobino, A. Prenatal exposure to ethanol: A specific effect on the H19 gene in sperm. Reprod. Toxicol. 2011, 31, 507-512.
224. Knezovich, J.G.; Ramsay, M. The effect of preconception paternal alcohol exposure on epigenetic remodeling of the h19 and rasgrf1 imprinting control regions in mouse offspring. Front. Genet. 2012, 3, 10.
225. Maccani, J.Z.; Koestler, D.C.; Houseman, E.A.; Marsit, C.J.; Kelsey, K.T. Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age. Epigenomics 2013, 5, 619-630.
226. Joubert, B.R.; Håberg, S.E.; Nilsen, R.M.; Wang, X.; Vollset, S.E.; Murphy, S.K.; Nystad, W.; Bell, D.A.; Peddada, S.D.; London, S.J. 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ. Health Perspect. 2012, 120, 1425-1432.
227. Li, Y.; Xiao, D.; Dasgupta, C.; Xiong, F.; Tong, W.; Yang, S.; Zhang, L. Perinatal nicotine exposure increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: Role of angiotensin II receptors. Stroke 2012, 43, 2483-2490.
228. Breton, C.V.; Byun, H.-M.; Wenten, M.; Pan, F.; Yang, A.; Gilliland, F.D. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit. Care Med. 2009, 180, 462-467.
229. Toledo-Rodriguez, M.; Lotfipour, S.; Leonard, G.; Perron, M.; Richer, L.; Veillette, S.; Pausova, Z.; Paus, T. Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2010, 153B, 1350-1354.
230. Chung, W.C.; Auger, A.P. Gender differences in neurodevelopment and epigenetics. Pflugers Arch. 2013, 465, 573-584.
231. Morrison, K.E.; Rodgers, A.B.; Morgan, C.P.; Bale, T.L. Epigenetic mechanisms in pubertal brain maturation. Neuroscience 2014, 264, 17-24.
232. Pagani, L.S. Environmental tobacco smoke exposure and brain development: The case of attention deficit/hyperactivity disorder. Neurosci. Biobehav. Rev. 2014, doi:10.1016/j.neubiorev.2013.03.008.
233. Novikova, S.I.; He, F.; Bai, J.; Cutrufello, N.J.; Lidow, M.S.; Undieh, A.S. Maternal cocaine administration in mice alters DNA methylation and gene expression in hippocampal neurons of neonatal and prepubertal offspring. PLoS One 2008, 3, e1919.
234. Anier, K.; Malinovskaja, K.; Aonurm-Helm, A.; Zharkovsky, A.; Kalda, A. DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology 2010, 35, 2450-2461.
235. Song, L.; James, S.R.; Kazim, L.; Karpf, A.R. Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Chem. 2005, 77, 504-510.
236. Itzhak, Y.; Ergui, I.; Young, J.I. Long-term parental methamphetamine exposure of mice influences behavior and hippocampal DNA methylation of the offspring. Mol. Psychiatry 2014, doi:10.1038/mp.2014.7.
237. Fragou, D.; Zanos, P.; Kouidou, S.; Njau, S.; Kitchen, I.; Bailey, A.; Kovatsi, L. Effect of chronic heroin and cocaine administration on global DNA methylation in brain and liver. Toxicol. Lett. 2013, 218, 260-265.
238. Clark, C.; Palta, P.; Joyce, C.J.; Scott, C.; Grundberg, E.; Deloukas, P.; Palotie, A.; Coffey, A.J. A comparison of the whole genome approach of MeDIP-seq to the targeted approach of the Infinium HumanMethylation450 BeadChip® for methylome profiling. PLoS One 2012, 7, e50233.
239. Olynik, B.M.; Rastegar, M. The genetic and epigenetic journey of embryonic stem cells into mature neural cells. Front. Genet. 2012, 3, 81.
240. Ezeonwuka, C.; Rastegar, M. MeCP2-related diseases and animal models. Diseases 2014, 2, 45-70.
241. Shahbazian, M.D.; Antalffy, B.; Armstrong, D.L.; Zoghbi, H.Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 2002, 11, 115-124.
242. Olson, C.O.; Zachariah, R.M.; Ezeonwuka, C.D.; Liyanage, V.R.; Rastegar, M. Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements. PLoS One 2014, 9, e90645.
243. Liyanage, V.R.; Zachariah, R.M.; Rastegar, M. Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Mol. Autism 2013, 4, 46.
244. Rastegar, M.; Hotta, A.; Pasceri, P.; Makarem, M.; Cheung, A.Y.; Elliott, S.; Park, K.J.; Adachi, M.; Jones, F.S.; Clarke, I.D.; et al. MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS One 2009, 4, e6810.
245. Renieri, A.; Meloni, I.; Longo, I.; Ariani, F.; Mari, F.; Pescucci, C.; Cambi, F. Rett syndrome: The complex nature of a monogenic disease. J. Mol. Med. 2003, 81, 346-354.
246. Amir, R.E.; van den Veyver, I.B.; Wan, M.; Tran, C.Q.; Francke, U.; Zoghbi, H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23, 185-188.
247. Lyst, M.J.; Ekiert, R.; Ebert, D.H.; Merusi, C.; Nowak, J.; Selfridge, J.; Guy, J.; Kastan, N.R.; Robinson, N.D.; de Lima Alves, F.; et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat. Neurosci. 2013, 16, 898-902.
248. Ebert, D.H.; Gabel, H.W.; Robinson, N.D.; Kastan, N.R.; Hu, L.S.; Cohen, S.; Navarro, A.J.; Lyst, M.J.; Ekiert, R.; Bird, A.P.; et al. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 2013, 499, 341-345.
249. Nagarajan, R.P.; Hogart, A.R.; Gwye, Y.; Martin, M.R.; LaSalle, J.M. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics 2006, 1, e1-e11.
250. Kuwano, Y.; Kamio, Y.; Kawai, T.; Katsuura, S.; Inada, N.; Takaki, A.; Rokutan, K. Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children. PLoS One 2011, 6, e24723.
251. Carney, R.M.; Wolpert, C.M.; Ravan, S.A.; Shahbazian, M.; Ashley-Koch, A.; Cuccaro, M.L.; Vance, J.M.; Pericak-Vance, M.A. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr. Neurol. 2003, 28, 205-211.
252. Beyer, K.S.; Blasi, F.; Bacchelli, E.; Klauck, S.M.; Maestrini, E.; Poustka, A. Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum. Genet. 2002, 111, 305-309.
253. Lam, C.W.; Yeung, W.L.; Ko, C.H.; Poon, P.M.; Tong, S.F.; Chan, K.Y.; Lo, I.F.; Chan, L.Y.; Hui, J.; Wong, V.; et al. Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J. Med. Genet. 2000, 37, E41.
254. Loat, C.S.; Curran, S.; Lewis, C.M.; Duvall, J.; Geschwind, D.; Bolton, P.; Craig, I.W. Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism. Genes Brain Behav. 2008, 7, 754-760.
255. Shibayama, A.; Cook, E.H., Jr.; Feng, J.; Glanzmann, C.; Yan, J.; Craddock, N.; Jones, I.R.; Goldman, D.; Heston, L.L.; Sommer, S.S. MECP2 structural and 3_-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. Am. J. Med. Genet B Neuropsychiatr. Genet. 2004, 128B, 50-53.
256. Coutinho, A.M.; Oliveira, G.; Katz, C.; Feng, J.; Yan, J.; Yang, C.; Marques, C.; Ataide, A.; Miguel, T.S.; Borges, L.; et al. MECP2 coding sequence and 3_UTR variation in 172 unrelated autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B, 475-483.
257. Peters, S.U.; Hundley, R.J.; Wilson, A.K.; Warren, Z.; Vehorn, A.; Carvalho, C.M.; Lupski, J.R.; Ramocki, M.B. The behavioral phenotype in MECP2 duplication syndrome: A comparison with idiopathic autism. Autism Res. 2013, 6, 42-50.
258. Xu, X.; Xu, Q.; Zhang, Y.; Zhang, X.; Cheng, T.; Wu, B.; Ding, Y.; Lu, P.; Zheng, J.; Zhang, M.; Qiu, Z.; Yu, X. A case report of Chinese brothers with inherited MECP2-containing duplication: Autism and intellectual disability, but not seizures or respiratory infections. BMC Med. Genet. 2012, 13, 75.
259. Zoll, B.; Huppke, P.; Wessel, A.; Bartels, I.; Laccone, F. Fetal alcohol syndrome in association with Rett syndrome. Genet. Couns. 2004, 15, 207-212.
260. Baker, S.A.; Chen, L.; Wilkins, A.D.; Yu, P.; Lichtarge, O.; Zoghbi, H.Y. An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 2013, 152, 984-996.
261. Kim, P.; Park, J.H.; Choi, C.S.; Choi, I.; Joo, S.H.; Kim, M.K.; Kim, S.Y.; Kim, K.C.; Park, S.H.; Kwon, K.J.; et al. Effects of ethanol exposure during early pregnancy in hyperactive, inattentive and impulsive behaviors and MeCP2 expression in rodent offspring. Neurochem. Res. 2013, 38, 620-631.
262. Romano-Lopez, A.; Mendez-Diaz, M.; Ruiz-Contreras, A.E.; Carrisoza, R.; Prospero-Garcia, O. Maternal separation and proclivity for ethanol intake: A potential role of the endocannabinoid system in rats. Neuroscience 2012, 223, 296-304.
263. Repunte-Canonigo, V.; Chen, J.; Lefebvre, C.; Kawamura, T.; Kreifeldt, M.; Basson, O.; Roberts, A.J.; Sanna, P.P. MeCP2 regulates ethanol sensitivity and intake. Addict. Biol. 2013, 19, 791-799.
264. Tunc-Ozcan, E.; Ullmann, T.M.; Shukla, P.K.; Redei, E.E. Low-dose thyroxine attenuates autism-associated adverse effects of fetal alcohol in male offspring's social behavior and hippocampal gene expression. Alcohol. Clin. Exp. Res. 2013, 37, 1986-1995.
265. Kim, P.; Choi, C.S.; Park, J.H.; Joo, S.H.; Kim, S.Y.; Ko, H.M.; Kim, K.C.; Jeon, S.J.; Park, S.H.; Han, S.H.; et al. Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring. J. Neurosci. Res. 2014, 92, 658-670.
266. Bekdash, R.A.; Zhang, C.; Sarkar, D.K. Gestational choline supplementation normalized fetal alcohol-induced alterations in histone modifications, DNA methylation, and proopiomelanocortin (POMC) gene expression in beta-endorphin-producing POMC neurons of the hypothalamus. Alcohol. Clin. Exp. Res. 2013, 37, 1133-1142.
267. Subbanna, S.; Nagre, N.N.; Shivakumar, M.; Umapathy, N.S.; Psychoyos, D.; Basavarajappa, B.S. Ethanol induced acetylation of histone at G9a exon1 and G9a-mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice. Neuroscience 2014, 258, 422-432.
268. Joyner, A.H.; Roddey, J.C.; Bloss, C.S.; Bakken, T.E.; Rimol, L.M.; Melle, I.; Agartz, I.; Djurovic, S.; Topol, E.J.; Schork, N.J.; et al. A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations. Proc. Natl. Acad. Sci. USA 2009, 106, 15483-15488.
269. Fumagalli, F.; Racagni, G.; Riva, M.A. The expanding role of BDNF: A therapeutic target for Alzheimer's disease? Pharmacogenomics J. 2006, 6, 8-15.
270. Couvert, P.; Bienvenu, T.; Aquaviva, C.; Poirier, K.; Moraine, C.; Gendrot, C.; Verloes, A.; Andres, C.; le Fevre, A.C.; Souville, I.; et al. MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet. 2001, 10, 941-946.
271. Watson, P.; Black, G.; Ramsden, S.; Barrow, M.; Super, M.; Kerr, B.; Clayton-Smith, J. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J. Med. Genet. 2001, 38, 224-228.
272. Olkhov-Mitsel, E.; Bapat, B. Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. Cancer Med. 2012, 1, 237-260.
273. Montano, C.M.; Irizarry, R.A.; Kaufmann, W.E.; Talbot, K.; Gur, R.E.; Feinberg, A.P.; Taub, M.A. Measuring cell-type specific differential methylation in human brain tissue. Genome Biol. 2013, 14, R94.
274. Guintivano, J.; Aryee, M.J.; Kaminsky, Z.A. A cell epigenotype specific model for the correction of brain cellular heterogeneity bias and its application to age, brain region and major depression. Epigenetics 2013, 8, 290-302.
275. Mainous, A., 3rd; Tanner, R.; Baker, R.; Zayas, C.; Harle, C. Prevalence of prediabetes in England from 2003 to 2011: Population-based, cross-sectional study. BMJ Open 2014, 4, e005002.
276. Volkmar, M.; Dedeurwaerder, S.; Cunha, D.A.; Ndlovu, M.N.; Defrance, M.; Deplus, R.; Calonne, E.; Volkmar, U.; Igoillo-Esteve, M.; Naamane, N.; et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012, 31, 1405-1426.
277. Dayeh, T.; Volkov, P.; Salö, S.; Hall, E.; Nilsson, E.; Olsson, A.H.; Kirkpatrick, C.L.; Wollheim, C.B.; Eliasson, L.; Rönn, T.; et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 2014, 10, e1004160.
278. Toperoff, G.; Aran, D.; Kark, J.D.; Rosenberg, M.; Dubnikov, T.; Nissan, B.; Wainstein, J.; Friedlander, Y.; Levy-Lahad, E.; Glaser, B.; et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum. Mol. Genet. 2012, 21, 371-383.
279. Bell, C.G.; Finer, S.; Lindgren, C.M.; Wilson, G.A.; Rakyan, V.K.; Teschendorff, A.E.; Akan, P.; Stupka, E.; Down, T.A.; Prokopenko, I.; et al. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One 2010, 5, e14040.
280. Levenson, V.V.; Melnikov, A.A. DNA methylation as clinically useful biomarkers-light at the end of the tunnel. Pharmaceuticals 2012, 5, 94-113.
281. Levenson, V.V. DNA methylation as a universal biomarker. Expert Rev. Mol. Diagn. 2010, 10, 481-488.
282. Papageorgiou, E.A.; Karagrigoriou, A.; Tsaliki, E.; Velissariou, V.; Carter, N.P.; Patsalis, P.C. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat. Med. 2011, 17, 510-513.
283. Marsit, C.J.; Lambertini, L.; MacCani, M.A.; Koestler, D.C.; Houseman, E.A.; Padbury, J.F.; Lester, B.M.; Chen, J. Placenta-imprinted gene expression association of infant neurobehavior. J. Pediatr. 2012, 160, 854-860.
284. Marsit, C.J.; Maccani, M.A.; Padbury, J.F.; Lester, B.M. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012, 7, e33794.
285. Maccani, M.A.; Padbury, J.F.; Lester, B.M.; Knopik, V.S.; Marsit, C.J. Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes. Pediatr. Res. 2013, 74, 272-278.